Litcius/Paper detail

Vertical Transmission and Neonatal Outcomes Following Maternal SARS-CoV-2 Infection During Pregnancy

Margaret H. Kyle, Maha Hussain, Victoria Saltz, Isabelle Mollicone, Mary Bence, Dani Dumitriu

2022Clinical Obstetrics & Gynecology31 citationsDOIOpen Access PDF

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over 200 million people worldwide and has likely exposed millions of neonates to SARS-CoV-2 in utero. A large body of literature has examined the possibility of vertical transmission from pregnant women infected with SARS-CoV-2 to their neonates. In this chapter, we review mechanisms of-and evidence for-vertical transmission of SARS-CoV-2, including transplacental, through other biospecimens and breastfeeding, and discuss neonatal outcomes following in utero exposure. Based on the available literature, we conclude vertical transmission of SARS-CoV-2 is rare, and exposed neonates generally show favorable health outcomes.

Topics & Concepts

PregnancyTransmission (telecommunications)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Neonatal infectionMedicine2019-20 coronavirus outbreakVirologyObstetricsBiologyInfectious disease (medical specialty)Computer scienceDiseaseInternal medicineGeneticsOutbreakTelecommunicationsCOVID-19 Impact on ReproductionPregnancy and Medication ImpactEctopic Pregnancy Diagnosis and Management
Vertical Transmission and Neonatal Outcomes Following Maternal SARS-CoV-2 Infection During Pregnancy | Litcius